Phase 1 study of safety, tolerability, PK and efficacy of AMG 510, a novel KRAS(G12C) inhibitor, evaluated in NSCLC Meeting Abstract
| Authors: | Govindan, R.; Fakih, M.; Price, T.; Falchook, G.; Desai, J.; Kuo, J.; Strickler, J.; Krauss, J.; Li, B.; Denlinger, C.; Durm, G.; Ngang, J.; Henary, H.; Ngarmchamnanrith, G.; Rasmussen, E.; Morrow, P.; Hong, D. |
| Abstract Title: | Phase 1 study of safety, tolerability, PK and efficacy of AMG 510, a novel KRAS(G12C) inhibitor, evaluated in NSCLC |
| Meeting Title: | 20th World Conference on Lung Cancer of the International Association for the Study of Lung Cancer (IASLC) |
| Keywords: | kras; kras(g12c); amg 510 |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 14 |
| Issue: | 10 |
| Meeting Dates: | 2019 Sept 7-10 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2019-10-01 |
| Start Page: | S208 |
| Language: | English |
| ACCESSION: | WOS:000492162201097 |
| DOI: | 10.1016/j.jtho.2019.08.412 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: OA02.02 -- Source: Wos |
